Webinars
Learn from the best in healthcare. We present you with real-time developments and actionable strategies. Register to ask your immediate questions and to access our slides.
October 6, 2021 12:00 - 1:00 PM ET Driving Vaccine Access and Uptake
Join us for a live conversation exploring actionable strategies for driving greater vaccine access and adoption.
July 22, 2021 12:00 - 1:00 PM ET Post-Pandemic Planning for Life Sciences Companies
Avalere’s data analytics and market access experts will be joined by Jeff Patton, MD and CEO of OneOncology, to explore critical issues and considerations for life sciences stakeholders following the pandemic.
May 27, 2021 2:00 - 3:00 PM ET Looking Ahead: The Evolving Oncology Landscape
Avalere experts examined the changing oncology landscape amid the COVID-19 pandemic.
April 28, 2021 12:00 - 1:00 PM ET Navigating Drug Pricing Proposals and the Role of Value
Join Avalere’s panel of data analytics, market access, and policy experts for a discussion on the potential for federal drug pricing reform in Congress or via administrative action.
March 11, 2021 11:00 - 12:00 PM ET Equity for Seniors: Using Data to Guide COVID-19 Pandemic Recovery
Join leading experts from Avalere Health and Tivity Health to learn more about new analyses detailing seniors’ lived experiences with the COVID-19 pandemic, including recent survey data on the vaccine rollout nationwide.
March 17, 2021 12:00 - 1:00 PM ET Understanding Shifting Insurance Coverage Impacts
Join Avalere’s panel of market access and policy experts to learn about the shifting insurance coverage landscape and how these trends impact manufacturers, payers, policymakers, and providers.
February 24, 2021 2:00 - 3:00 PM ET COVID-19: Lessons Learned and the Path Forward
Join Avalere’s panel of policy, public health, and regulatory experts to learn about the challenges, opportunities, and key milestones to watch.
January 7, 2021 1:00 - 2:00 PM ET Avalere 2021 Healthcare Industry Outlook: Clearing the Path
The accelerated changes and increased uncertainties in healthcare brought on by the COVID-19 pandemic will continue into 2021, and its impacts are likely to shape healthcare for years to come. While prevalent uncertainty is a given, the broad outline of a new era is already emerging. More than ever, careful examination of healthcare stakeholder’s business models, policy developments, and data will be essential to arrive at accurate assessments of the future state. Our experts engaged in a live discussion covering critical issues facing healthcare leaders and strategies for clearing the path.
For even deeper coverage, download the 2021 Healthcare Industry Outlook document below.
November 5, 2020 2:00 - 2:30 PM ET 2020 Election with Avalere: What’s at Stake for Healthcare Post-Election?
Avalere experts discussed how the 2020 election is influencing the future of healthcare.
October 21, 2020 1:00 - 2:00 PM ET What’s Next for Oncology Care Management and Payment?
Avalere experts took a closer look at emerging oncology trends, innovative approaches to payment and delivery, and what these changes will mean for patient access.
September 16, 2020 12:00 - 1:00 PM ET Market Access Enablement Strategies, Part 1: Launching in a Virtual World
Join Avalere experts for Part 1 of our Market Access Enablement Strategies webinar series to learn about how life sciences companies are pivoting with pre-/post-new product launch strategies, including differential investments to inform market access execution.
September 22, 2020 12:00 - 1:00 PM ET Market Access Enablement Strategies, Part 2: Navigating Policy and Marketplace Developments
Join Avalere experts for Part 2 of our Market Access Enablement Strategies webinar series to learn about the policy changes and market factors that could impact the future relationships between manufacturers, health plans, and pharmacy benefit managers.
August 11, 2020 12:00 - 1:00 PM ET Election 2020 and Healthcare: Setting the Stage
Avalere’s 2020 Election series started with our experts covering the current state of play in the 2020 election and the role of healthcare between now and November.
July 22, 2020 12:30 - 1:30 PM ET Cutting Through the Noise: Market Evolution and Pathways to Access for COVID-19 Vaccines and Therapeutics
Avalere experts discussed the marketplace for COVID-19 vaccines and therapeutics, including key decision points for regulatory pathways, pricing, and distribution scenarios for optimal US and EX-US market access.
June 11, 2020 1:00 - 2:00 PM ET The Impact of Telehealth on the Future Care-Delivery Landscape
Avalere experts explored the future role of telehealth and how organizations can help shape and take advantage of its increased utilization.
June 9, 2020 1:00 - 2:00 PM ET New Data Analytics Approaches for Novel Curative Therapies & APMs
Avalere experts discussed new data analytics and health economics and outcomes research approaches for evaluating key value-based topics in healthcare, including novel curative therapy affordability and access, alternative payment models, and the increasingly important role of real-world evidence in healthcare decision-making.
May 13, 2020 1:30 - 2:15 PM ET Evolving COVID-19 Impacts on Health Insurance Enrollment
Avalere experts discussed the key issues and considerations for the healthcare industry as millions of Americans shift in and out of new sources of coverage.
April 30, 2020 1:00 - 2:00 PM ET Understanding Shifts from Medicare Part B to D in Autoimmune Treatment
Avalere experts examined evolving stakeholder-specific considerations for reshaping how patients with autoimmune conditions receive care during and after the COVID-19 pandemic.
April 23, 2020 1:30 - 2:30 PM ET Guiding Patients on Care Journeys: Preparing for Shared Decision-Making
Experts from Avalere and the National Patient Advocate Foundation (NPAF) discussed the value of shared decision-making (SDM) and preparing patients and families for navigating their care journeys.
April 9, 2020 2:00 - 3:00 PM ET The Impact of COVID-19 on the Health Insurance Industry
Our panel of experts engaged in an in-depth discussion of the rapidly evolving regulatory environment surrounding COVID-19 testing and treatment and the strategic, financial, and operational challenges this disease presents for health insurers.
